Gunnar Juliusson
51 – 60 of 159
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells
- Contribution to journal › Article
-
Mark
A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma
- Contribution to journal › Article
-
Mark
Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register
- Contribution to journal › Article
-
Mark
Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia : A population-based study from the Swedish AML registry
- Contribution to journal › Article
-
Mark
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
- Contribution to journal › Article
-
Mark
Chronic lymphocytic leukemia with mutated IGHV4-34 receptors : Shared and distinct immunogenetic features and clinical outcomes
- Contribution to journal › Article
-
Mark
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
- Contribution to journal › Scientific review
- 2016
-
Mark
Acute myeloid leukemia in adolescents and young adults treated in pediatric and adult departments in the nordic countries.
- Contribution to journal › Article
-
Mark
Leukemia
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
An open-label phase I dose-finding study of APR-246 in hematological malignancies
- Contribution to journal › Article
